Catherine T. Doherty
Executive Vice President at Quest Diagnostics. Based in Secaucus, New Jersey.
- Rank
- 5230th of 14,644
- Companies held
- 1
- Largest holding
- DGX, 100.0% of total
- Latest SEC filing
- Nov 3, 2026
What the $19.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Quest Diagnostics DGX Common Stock | Directly | 71,949 | $259.09 | $18.6M | 94.0% | Form 4, Nov 3, 2026 |
| Quest Diagnostics DGX Common Stock | Indirectly (see filing footnote) | 4,552 | $259.09 | $1.2M | 6.0% | Form 4, Nov 3, 2026 |
Share counts are the amounts Catherine T. Doherty reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Sold | DGX | 3,818 | $245.45 | $937K | View |
| Nov 3, 2026 | Sold | DGX | 5,990 | $246.26 | $1.5M | View |
| Nov 3, 2026 | Sold | DGX | 1,151 | $246.98 | $284K | View |
| Nov 3, 2026 | Sold | DGX | 2,358 | $248.38 | $586K | View |
| Nov 3, 2026 | Sold | DGX | 3,004 | $249.40 | $749K | View |
| Nov 3, 2026 | Sold | DGX | 2,877 | $250.49 | $721K | View |
| Nov 3, 2026 | Sold | DGX | 2,907 | $251.24 | $730K | View |
| Mar 5, 2026 | Sold | DGX | 5,558 | $206.21 | $1.1M | View |
| Mar 3, 2026 | Sold | DGX | 632 | $207.73 | $131K | View |
| Feb 19, 2026 | Sold | DGX | 1,433 | $204.83 | $294K | View |
| Feb 13, 2026 | Sold | DGX | 10,122 | $206.37 | $2.1M | View |
| Feb 13, 2026 | Sold | DGX | 10,573 | $205.21 | $2.2M | View |
| Feb 13, 2026 | Sold | DGX | 351 | $209.10 | $73K | View |
| Feb 13, 2026 | Sold | DGX | 1,619 | $208.21 | $337K | View |
| Feb 13, 2026 | Sold | DGX | 3,500 | $207.08 | $725K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5227 | R. Jarrett Lilien President and COO, WisdomTree. New York, NY | $19.8M |
| 5228 | Kirk B. Griswold Director, Bentley Systems. Exton, PA | $19.8M |
| 5229 | Linden R. Evans President and CEO, Bright Horizon Energy. Rapid City, SD | $19.8M |
| 5230 | Catherine T. Doherty Executive Vice President, Quest Diagnostics. Secaucus, NJ | $19.8M |
| 5231 | Greg A. Steffens CHAIRMAN/CEO, Southern Missouri Bancorp. Poplar Bluff, MO | $19.8M |
| 5232 | D. Scott Pryor See Remarks, Targa Resources. Houston, TX | $19.8M |
| 5233 | Constance H. Lau Director, Matson. Honolulu, HI | $19.8M |
Other Quest Diagnostics insiders
All DGX insiders- Stephen H. Rusckowski$101MDirector. #1454 overall
- J. E. Davis$31.7MCEO and President. #3629 overall
- Mark J. Guinan$25.6MExecutive Vice President & CFO. #4286 overall
- Manner Carrie Eglinton$12.5MSVP, Advanced Diagnostics. #4930 overall
- Michael E. Prevoznik$11.0MSVP & General Counsel. #8177 overall
- Michael J. Deppe$9.3MSVP, Corp. Controller & CAO. #9268 overall
Questions
How much stock does Catherine T. Doherty own?
Catherine T. Doherty holds $19,820,644 in listed stock based on SEC filings and current prices, mostly Quest Diagnostics (DGX). That ranks 5230th on the Stock Rich List.
Is this Catherine T. Doherty's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Catherine T. Doherty last buy or sell stock?
The most recent open-market trade on file is a sale of 3,818 DGX shares on Nov 3, 2026 at $245.45.